AEON Biopharma to Host Key Opinion Leader Webinar on Past, Present, and Potential Future Treatments for Migraine on February 24th
Live event scheduled for Friday, February 24th at 11:00 am Eastern Time IRVINE, Calif., Feb….
Month: February 2023
Vaxart Doses First Subject in the Phase 2 Clinical Trial of its Bivalent Norovirus Candidate
Study to evaluate safety and immunogenicity of oral norovirus vaccine in healthy adults SOUTH SAN…
Propella Therapeutics Announces Presentation of Updated Phase 1/2a Data of PRL-02 for the Treatment of Advanced Prostate Cancer at 2023 ASCO Genitourinary (GU) Cancers Symposium
PRL-02 continues to demonstrate strong safety along with dose-dependent reductions in testosterone and PSA Recently…
Sensei Biotherapeutics to Present New Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Keystone Symposia on Next Generation Antibody Therapeutics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (ublituximab) in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule…
KKR-backed Replay and MD Anderson form new product company Syena to pioneer first-in-class TCR-NK cell therapy
KKR-backed Replay and MD Anderson form new product company Syena to pioneer first-in-class TCR-NK cell…
Plus Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
AUSTIN, Texas, Feb. 14, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Gritstone bio and the National Cancer Institute (NCI) Establish a Clinical Trial Agreement to Evaluate a Neoantigen Cell Therapy-Vaccine Combination
— NCI will lead the Phase 1 study using Gritstone’s proprietary “off the shelf” vaccine…
Monopar Announces Camsirubicin Clinical Program Update – Improved Side Effect Profile Seen to Date Compared to Doxorubicin
WILMETTE, Ill., Feb. 14, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
– Three-Month and Nine-Month Losses decline by 84.2% and 73.5%, respectively – Operating Cash Outflows for…
Breckenridge Distillery Strikes Gold at 2023 World Whiskies Awards
The World’s Highest Distillery Earns Three Top Prizes for This Year’s World Whiskies Awards for…
Acasti Pharma Reports Third Quarter 2023 Operational Results
Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE…
Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023
PHILADELPHIA, Feb. 14, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the…
Clear Street Welcomes IMC as a Strategic Investor
The investment will support the fintech’s mission to build better infrastructure for capital markets NEW…
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
MALVERN, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage…
MasterControl Insights Is Now Available in Manufacturing Excellence
Users have unprecedented visibility into operations to increase productivity SALT LAKE CITY, Feb. 14, 2023…
EbixCash Becomes the First to Launch UPI for Foreign Nationals visiting India
NOIDA, India and JOHNS CREEK, Ga., Feb. 14, 2023 (GLOBE NEWSWIRE) — EbixCash Limited, a…
Supply Chains Suffer from Disruptions Caused by Earthquake in Turkey
Supply Chain Risk Analysis and Network Optimization Will Set the Stage for Resilience NEW FREEDOM,…
San Jose Water Expands Locus Technologies SaaS to include GIS+
Locus GIS+ will streamline SJW’s water quality and environmental management from watershed to consumer taps….
Nexalogy Set to Present Analytics GPT This Month
Toronto, Ontario–(Newsfile Corp. – February 14, 2023) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…